The FDA has repeatedly warned about dosing errors and safety issues with compounded semaglutide and tirzepatide, including hospitalizations
Twenty-five thousand patients are starting this medication weekly in the US alone
By improving dopamine regulation, semaglutide can help people manage their cravings and reduce overeating, leading to better weight loss outcomes
To a large extent, the FDA created this problem themselves, said Ball
Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 7.5 mg/0.6 mL Dose (30 mg/2.4 mL [12.5 mg/mL]) Rx Only NDC 0002-6210-11 Zepbound (tirzepatide) injection 30 mg/2.4 mL (12.5 mg/mL) ATTENTION: Contains 4 doses of 7.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
Prior to this research, the middle of the equation GLP-1 and satiation deficits was completely missing, and that missing part is crucial for advancing treatment for bulimia and related disorders, Keel said
